Adipocyte-derived exosomes from obstructive sleep apnoea rats aggravate MASLD by TCONS_00039830/miR-455-3p/Smad2 axis

Li Yang1,2, Yan He3,4, Shijie Liu3,4

  • 1Hypertension Center, Yan 'an Hospital of Kunming, Kunming, China. yl13330466619@163.com.

Communications Biology
|April 23, 2024
PubMed

Insights

Obstructive sleep apnoea (OSA) worsens metabolic dysfunction-associated steatotic liver disease (MASLD) by promoting hepatocyte steatosis. OSA-derived exosomes regulate the TCONS-00039830/miR-455-3p/Smad2 pathway, aggravating liver damage in MASLD patients.

Area of Science:

  • Hepatology
  • Sleep Medicine
  • Molecular Biology

Background:

  • Obstructive sleep apnoea (OSA) is linked to increased severity of metabolic dysfunction-associated steatotic liver disease (MASLD).
  • The precise molecular mechanisms by which OSA exacerbates MASLD remain largely undetermined.
  • Adipocyte-derived exosomes are implicated in intercellular communication and may play a role in this interaction.

Purpose of the Study:

  • To investigate the role of adipocyte-derived exosomes in OSA-induced MASLD aggravation.
  • To elucidate the molecular mechanisms underlying the interplay between OSA and MASLD.

Main Methods:

  • Exosome isolation and characterization.
  • RNA sequencing to identify differentially expressed miRNAs and LncRNAs.
  • In vivo and in vitro experiments using cell transfection and exosome administration.
  • Validation of gene and miRNA expression levels.

Main Results:

  • miR-455-3p was identified as a co-differentially expressed miRNA in MASLD+OSA versus control and MASLD groups.
  • LncRNA TCONS-00039830 and Smad2 were upregulated, while miR-455-3p was downregulated in MASLD and MASLD+OSA models.
  • TCONS-00039830 overexpression increased lipid accumulation; miR-455-3p overexpression reduced it.
  • OSA-derived exosomes promoted steatosis via the TCONS-00039830/miR-455-3p/Smad2 axis.

Conclusions:

  • Adipocyte-derived exosomes from OSA patients promote hepatocyte steatosis.
  • The TCONS-00039830/miR-455-3p/Smad2 axis is a key molecular pathway mediating OSA's exacerbation of MASLD.
  • Targeting this exosomal pathway may offer therapeutic strategies for MASLD.

Related Concept Videos